Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma.
Le Chevalier
T
T
Institut Gustave Roussy, Villejuif, France.
Zabbe
C
C
Gouva
S
S
Cerrina
M L
ML
Quoix
E
E
Riviere
A
A
Berthaud
P
P
Prache
C
C
Berille
J
J
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; C054368:fotemustine